Skip to main content
. 2021 Nov 27;13(11):1338–1350. doi: 10.4240/wjgs.v13.i11.1338

Table 3.

Clinical outcomes of surgical ampullectomy

Indication
Outcome

Estimate
Ref.
Adenoma or AAC Complete excision (R0) 96.4% [38]
Adenoma or AAC Recurrence 9.4% [38]
Adenoma or AAC Complications 28.3% [38]
Adenoma or AAC Mortality1 0.9% [6,12,14,20,22,24,25,28,30,32,39,41,43,45,47-52,58,62,64,67,72,74,76-79]
AAC Survival at 5 yr T1 40% [50]
T1 + T2 64.3% [41]
T2 16% [50]
T3 0% [50]
T3 + T4 18.2% [41]
1

Pooled mortality of cited studies (5 deaths in 532 surgical ampullectomies across 30 studies).

AAC: Ampullary adenocarcinoma.